What the Fed?
Stories Chat Explore
Stories Chat Explore Explore Bills Votes Records Members Daily Briefing Following Privacy & analytics
Some controls are taking longer to load.

H.R. 10369 · 119th Congress

Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026

Stage
In committee
Sponsor
Ryan Mackenzie
Introduced
2026-09-14
Latest action
2026-09-14 · Introduced in House
Summary Text Subjects Cosponsors (4) Votes (0) Actions

Text

Information only, not legal advice. AI can make mistakes. Always verify important information with reliable sources or a qualified professional. Privacy About this project

Manage analytics

One choice covers this website and its app in this browser. Optional Google Analytics 4 and PostHog analytics help us understand visits and app use. We never send chat prompts, search text, annotations, or the people and issues you follow.

Read the privacy policy
Help improve What the Fed?

With your permission, we collect limited product-use data through PostHog and Google Analytics 4 to understand which parts of this website and its app are useful. We never send chat prompts, search text, annotations, or the people and issues you follow.

Read the privacy policy